understanding the cause of tki resistance to improve management strategies in cml
Published 1 year ago • 161 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
6:22
efficacy & tolerability of available tki therapies in cml & managing tki resistance
-
2:11
addressing the issue of resistance to tkis in cml
-
1:42
managing cardiovascular risks associated with lifelong tki therapy in cml
-
1:12
the role of cml stem cells in relapse after tki discontinuation & resistance to treatment
-
2:00
novel treatment strategies for patients with cml who are intolerant or resistant to available tkis
-
3:57
what is chronic lymphocytic leukaemia?
-
3:34
understanding chronic lymphocytic leukemia (cll): causes, signs, symptoms, and treatment
-
12:26
esc guidelines: diagnosis of chronic hf (english version)
-
1:00
the role of flot2 in cml progression & how it differs from aml
-
0:55
managing adverse events associated with tkis in cml
-
1:38
outlook for the management of chronic myeloid leukemia
-
2:08
an insight into the current understanding of risk factors for cll
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
2:07
esh cml highlights: michele baccarani symposium - understanding the significance of mutations in cml
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
1:24
ongoing studies in cml: investigating asciminib toxicity and improving tfr rates
-
1:39
emerging therapeutic approaches for tki-resistant cml
-
4:25
metabolic vulnerabilities in cml & the impact of tkis on glucose anaplerosis
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
2:15
resistance/intolerance to second generation tkis in cml: what to do next?
-
4:33
optimizing discontinuation of tyrosine kinase inhibitor treatment for chronic myeloid leukemia